Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Alpenglow Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Alpenglow Biosciences

Alpenglow Biosciences

Alpenglow Biosciences: Accelerating drug development with AI-enabled 3D imaging technology since 2018.

HQ
Seattle, WA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded in 2018, Seattle-based Alpenglow Biosciences is a privately held life sciences company dedicated to accelerating drug development and enhancing clinical diagnostics through AI-enabled 3D imaging technology. Their innovative platform offers new spatial biology insights, providing greater accuracy and depth in biological research and medical diagnostics. Alpenglow Biosciences primarily focuses on the pharmaceutical and healthcare markets, aiming to revolutionize how diseases are understood and treated.

Notable figures affiliated with Alpenglow Biosciences include experts in AI, imaging, and life sciences, although specific names are not provided. The company has attracted attention from key investors in the biotech industry, contributing to its rapid growth and development. Alpenglow Biosciences' achievements include pioneering advancements in 3D spatial biology that have significant implications for drug development and clinical diagnostics, positioning the company as a leader in the integration of AI and imaging technologies in life sciences.

Alpenglow Biosciences - Similar Companies

Alamar Biosciences logo

Alamar Biosciences

alamarbio.com

Alzeca Biosciences logo

Alzeca Biosciences

alzeca.com

Algen Biotechnologies logo

Algen Biotechnologies

algenbio.com

Elucid Bioimaging logo

Elucid Bioimaging

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Amplified Sciences logo

Amplified Sciences

Magnify Biosciences logo

Magnify Biosciences

magnifybiosci.com

Avelas Biosciences logo

Avelas Biosciences

Longevity InTime BioTech logo

Longevity InTime BioTech

intime.digital

OneThree Biotech logo

OneThree Biotech

onethree.bio

Alveo Technologies logo

Alveo Technologies

Enable Medicine logo

Enable Medicine

enablemedicine.com

Curi Bio logo

Curi Bio

curibio.com

Lumen Bioscience logo

Lumen Bioscience

BioAI Health logo

BioAI Health

bioaihealth.com

Alpenglow Biosciences - Quick Facts

Who are Alpenglow Biosciences' competitors?

Companies similar to Alpenglow Biosciences include Alamar Biosciences, Alzeca Biosciences, Algen Biotechnologies and Elucid Bioimaging.

When was Alpenglow Biosciences founded?

Alpenglow Biosciences was founded in 2018.

Where is Alpenglow Biosciences' headquarters located?

Alpenglow Biosciences' headquarters is located in Seattle, WA, US.

When was Alpenglow Biosciences' last funding round?

Alpenglow Biosciences' most recent funding round was for $1.6M (USD) in August 2023.

How much has Alpenglow Biosciences raised to-date?

As of Aug 1, 2023, Alpenglow Biosciences has raised a total of $5.6M (USD).

How many employees does Alpenglow Biosciences have?

Alpenglow Biosciences has 22 employees as of Feb 4, 2024.

Alpenglow Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Imaging
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified